Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Feb 2012 When the Physician's Medical Judgment is Rejected, Commentary 2 Robert E. Cranston, MD Physicians must maintain a delicate balance between patient autonomy and preventing harm when faced with patients who refuse treatment. Virtual Mentor. 2012;6(2):82-85. doi: 10.1001/virtualmentor.2004.6.2.ccas2-0402. Case and Commentary Feb 2004 When the Physician's Medical Judgment is Rejected, Commentary 1 Kirsten G. Engel, MD Physicians must maintain a delicate balance between patient autonomy and preventing harm when faced with patients who refuse treatment. Virtual Mentor. 2004;6(2):78-81. doi: 10.1001/virtualmentor.2004.6.2.ccas2-0402. Case and Commentary Feb 2004 Paternalism, Commentary 1 Anne Drapkin Lyerly, MD Physicians should not refuse to perform a medical procedure because of an emotionally charged reaction to the patients' behavior. Virtual Mentor. 2004;6(2):72-75. doi: 10.1001/virtualmentor.2004.6.2.ccas1-0402. Case and Commentary Feb 2004 Finding the Balance in Shared Decision Making, Commentary 1 Ellen Painter Dollar Physicians need to manage parental treatment decisions when the decisions conflict with medical judgment. Virtual Mentor. 2004;6(2):86-88. doi: 10.1001/virtualmentor.2004.6.2.ccas3-0402. Case and Commentary Feb 2004 Finding the Balance in Shared Decision Making, Commentary 2 Daniel A. Beals, MD Physicians need to manage parental treatment decisions when the decisions conflict with medical judgment. Virtual Mentor. 2004;6(2):89-91. doi: 10.1001/virtualmentor.2004.6.2.ccas3-0402. Case and Commentary Feb 2004 Paternalism, Commentary 2 Barbara Katz Rothman, PhD Physicians should not refuse to perform a medical procedure because of an emotionally charged reaction to the patients' behavior. Virtual Mentor. 2004;6(2):76-77. doi: 10.1001/virtualmentor.2004.6.2.ccas1-0402. Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication. Virtual Mentor. 2004;6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408. State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Pagination First page « First Previous page ‹ Previous … Page 33 Page 34 Page 35 Page 36 Page 37 Page 38 Current page 39 Page 40 Page 41 Next page Next › Last page Last »
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Feb 2012 When the Physician's Medical Judgment is Rejected, Commentary 2 Robert E. Cranston, MD Physicians must maintain a delicate balance between patient autonomy and preventing harm when faced with patients who refuse treatment. Virtual Mentor. 2012;6(2):82-85. doi: 10.1001/virtualmentor.2004.6.2.ccas2-0402.
Case and Commentary Feb 2004 When the Physician's Medical Judgment is Rejected, Commentary 1 Kirsten G. Engel, MD Physicians must maintain a delicate balance between patient autonomy and preventing harm when faced with patients who refuse treatment. Virtual Mentor. 2004;6(2):78-81. doi: 10.1001/virtualmentor.2004.6.2.ccas2-0402.
Case and Commentary Feb 2004 Paternalism, Commentary 1 Anne Drapkin Lyerly, MD Physicians should not refuse to perform a medical procedure because of an emotionally charged reaction to the patients' behavior. Virtual Mentor. 2004;6(2):72-75. doi: 10.1001/virtualmentor.2004.6.2.ccas1-0402.
Case and Commentary Feb 2004 Finding the Balance in Shared Decision Making, Commentary 1 Ellen Painter Dollar Physicians need to manage parental treatment decisions when the decisions conflict with medical judgment. Virtual Mentor. 2004;6(2):86-88. doi: 10.1001/virtualmentor.2004.6.2.ccas3-0402.
Case and Commentary Feb 2004 Finding the Balance in Shared Decision Making, Commentary 2 Daniel A. Beals, MD Physicians need to manage parental treatment decisions when the decisions conflict with medical judgment. Virtual Mentor. 2004;6(2):89-91. doi: 10.1001/virtualmentor.2004.6.2.ccas3-0402.
Case and Commentary Feb 2004 Paternalism, Commentary 2 Barbara Katz Rothman, PhD Physicians should not refuse to perform a medical procedure because of an emotionally charged reaction to the patients' behavior. Virtual Mentor. 2004;6(2):76-77. doi: 10.1001/virtualmentor.2004.6.2.ccas1-0402.
Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication. Virtual Mentor. 2004;6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408.
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.